Wu Sheng Long - Net Worth and Insider Trading
Wu Sheng Long Net Worth
The estimated net worth of Wu Sheng Long is at least $4 Million dollars as of 2024-12-11. Wu Sheng Long is the senior management of KPC Pharmaceuticals Inc and owns about 256,000 shares of KPC Pharmaceuticals Inc (SHSE:600422) stock worth over $4 Million. Details can be seen in Wu Sheng Long's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Sheng Long has not made any transactions after 2021-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wu Sheng Long
Wu Sheng Long Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Sheng Long owns 1 companies in total, including KPC Pharmaceuticals Inc (SHSE:600422) .
Click here to see the complete history of Wu Sheng Long’s form 4 insider trades.
Insider Ownership Summary of Wu Sheng Long
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600422 | KPC Pharmaceuticals Inc | 2021-06-07 | senior management |
Wu Sheng Long Latest Holdings Summary
Wu Sheng Long currently owns a total of 1 stock. Wu Sheng Long owns 256,000 shares of KPC Pharmaceuticals Inc (SHSE:600422) as of June 7, 2021, with a value of $4 Million.
Latest Holdings of Wu Sheng Long
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600422 | KPC Pharmaceuticals Inc | 2021-06-07 | 256,000 | 15.84 | 4,055,040 |
Holding Weightings of Wu Sheng Long
Wu Sheng Long Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Sheng Long has made a total of 1 transactions in KPC Pharmaceuticals Inc (SHSE:600422) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in KPC Pharmaceuticals Inc is the sale of 256,000 shares on June 7, 2021, which brought Wu Sheng Long around $1 Million.
Insider Trading History of Wu Sheng Long
- 1
Wu Sheng Long Trading Performance
GuruFocus tracks the stock performance after each of Wu Sheng Long's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Sheng Long is 0.21%. GuruFocus also compares Wu Sheng Long's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Sheng Long within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Sheng Long's insider trading performs compared to the benchmark.
Performance of Wu Sheng Long
Wu Sheng Long Ownership Network
Ownership Network List of Wu Sheng Long
Ownership Network Relation of Wu Sheng Long
Wu Sheng Long Owned Company Details
What does KPC Pharmaceuticals Inc do?
Who are the key executives at KPC Pharmaceuticals Inc?
Wu Sheng Long is the senior management of KPC Pharmaceuticals Inc. Other key executives at KPC Pharmaceuticals Inc include senior management Qu Xiao Ru , senior management Xie Bo , and senior management Meng Li .
KPC Pharmaceuticals Inc (SHSE:600422) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
KPC Pharmaceuticals Inc (SHSE:600422)'s detailed insider trading history can be found in Insider Trading Tracker table.
KPC Pharmaceuticals Inc Insider Transactions
Wu Sheng Long Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Sheng Long. Currently GuruFocus does not have mailing address information for Wu Sheng Long.